Global Fertility Test Market (2020 to 2025) - Online Sales of Fertility Testing Devices Presents Opportunities - ResearchAndMarkets.com

·4 min read

The "Fertility Test Market by Product (Ovulation Predictor Kits, Fertility Monitors (Urine, Saliva, Blood)), Mode of Purchase (OTC, Prescription, Online), Application (Female, Male), End User (Home care, Fertility clinics, hospitals) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The fertility test market is projected to reach USD 680 Million by 2025 from USD 472 Million in 2020, at a CAGR of 7.5% the forecast period.

Growth in this market is primarily driven by the increasing first-time pregnancy age in women, declining fertility rate among men and women, growing number of women suffering from disorders such as PCOS, emergence of advanced ovulation monitors, and the increased awareness of fertility testing in both developed as well as developing countries.

In terms of Purchase mode, OTC segment to register significant growth during the forecast period..

Based on the mode of purchase, the fertility test market is segmented into direct/prescription, OTC, and online products. In 2020 the OTC segment had the major market share and exhibited high growth. The high growth of this segment is attributed to the inclination of patients towards self-monitoring of healthcare conditions, increasing initiatives by market players to spread awareness on fertility, and the rising preference for confidentiality and accessibility of test results.

In terms Application, the female fertility testing segment is expected to account for the largest share of the fertility test market in 2020.

Based on the application, the fertility test market is segmented into female fertility testing and male fertility testing. In 2020, the female fertility testing segment accounted for a larger market share, primarily due to the decreasing female fertility rates, availability of a wide range of fertility testing options for females, increase in gynecological issues in women (such as PCOD/PCOS), and the high cost of IVF procedures.

In terms of product segment, ovulation prediction kits segment is expected to account for the largest share during the forecast period.

Based on products, the fertility test market is segmented into ovulation prediction kits, fertility monitors & male fertility testing products. A large share is attributed to the ovulation prediction kits segment due to the increasing use of ovulation prediction kits, easy over-the-counter availability and low cost, and higher accuracy than natural fertility testing techniques, such as calendar methods and cervical mucus monitoring.

The home care settings segment is expected to register the highest CAGR during the forecast period `

Based on end-users, the fertility test market has been segmented based on end-user category-home care settings, hospitals and fertility clinics, and other end users. The large share and high growth of this segment can be attributed to the inclination of patients toward self-monitoring of healthcare conditions, easy access to fertility and ovulation monitors on e-commerce websites, availability of user-friendly and easy-to-handle devices, and the growing preference for the confidentiality of test results.

Asia Pacific market is expected to grow at the highest CAGR during the forecast period.

The Asia Pacific market is projected to register the highest CAGR during the forecast period. Growth in the Asia Pacific market is majorly due to the growing number of women suffering from lifestyle disorders, increasing funding/investments toward the development of fertility and ovulation monitors, and the growing focus of both international and domestic players on the Asia Pacific fertility test market.

Market Dynamics

Drivers

  • Increasing First-Time Pregnancy Age

  • Declining Fertility Rates Across the Globe

  • Growing Population of Women of Reproductive Age

  • Launch of Advanced, Easy-To-Use Fertility Testing Devices with High Accuracy

  • Increasing Awareness of Fertility Testing

  • Growing Number of Gynecological and Reproductive Issues in Women and Men

Restraints

  • Lesser Precision of Ovulation Prediction Kits

  • Unproven Accuracy of Urine-Based Ovulation Monitors in Pcos/Pcod Patients

Opportunities

  • Emergence of Combined Kits for Dual Testing of Pregnancy and Ovulation

  • Emerging Nations to Offer New Growth Avenues

  • Online Sales of Fertility Testing Devices

  • High Cost and Low Accuracy of Ivf Treatment

Challenges

  • High Cost of Fertility Testing Monitors

Companies Mentioned

  • Advacare Pharma

  • Ava

  • Babystart (Snowden Healthcare)

  • Biozhena

  • Church & Dwight

  • Exseed Health

  • Fairhaven Health

  • Fertility FocUS

  • Geratherm Medical

  • Hilin Life Products

  • Medical Electronic Systems

  • Mira Care

  • Pregmate

  • Prestige Brands Holdings

  • Sensiia

  • Swim Count (Subsidiary of Motiltycount APS)

  • Swiss Precision Diagnostics

  • Tempdrop

  • Uebe Medical

  • Valley Electronics

For more information about this report visit https://www.researchandmarkets.com/r/rdlpyf

View source version on businesswire.com: https://www.businesswire.com/news/home/20210412005589/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900